Overview

A Study of SHR0410 in Hemodialysis Patients With Pruritus

Status:
Recruiting
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety, tolerability and pharmacokinetics of SHR0410 in hemodialysis patients with moderate to severe pruritus
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.